Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Platelet count

SLFN14 · rs8073060

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−40, with 11 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 166,066 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.03 higher (95% confidence interval 0.022-0.038); p = 9 × 10−14.

How common The A allele had a frequency of about 29% in the people studied.

Where it sits Chromosome 17, band 17q12 — a missense change in SLFN14.

What ClinVar records

Classification Benign/Likely benign for Platelet-type bleeding disorder 20; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 5 submitters), last evaluated 2024-11-28. ClinVar record 1245977 NM_001129820.2(SLFN14):c.2735A>T (p.Tyr912Phe)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-09 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AT
Korean KRGDB
A 17.0% · T 83.0%
Korean Korea4K
A 15.3% · T 84.7%
Korean Korea1K
A 15.5% · T 84.5%
Japanese ToMMo
A 13.2% · T 86.9%
Vietnamese
A 15.7% · T 84.3%
World gnomAD
A 33.9% · T 66.1%
World 1000 Genomes
A 35.0% · T 65.0%
World TOPMed
A 34.7% · T 65.3%

By ancestry gnomAD

East Asian
A 17.7% · T 82.3%
European (non-Finnish)
A 29.4% · T 70.6%
African / African American
A 45.6% · T 54.4%
South Asian
A 39.3% · T 60.7%
Admixed American (Latino)
A 30.7% · T 69.3%
Middle Eastern
A 43.2% · T 56.8%
Finnish
A 24.2% · T 75.8%
Ashkenazi Jewish
A 40.8% · T 59.2%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Platelet count. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/T One copy of the version the research linked to Platelet count. That is a smaller link than two copies.
T/T No copy of the version the research linked to Platelet count. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Platelet count (rs8073060). MyGeneLog™. https://www.mygenelog.com/variants/rs8073060

← See all variants